Fig. 5From: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells a MCF-7 cells and RFP-MSC (untreated or cisplatin pretretreated) were co-cultured for 5Â days and subsequently sorted according to expression of fluorescent marker. Gene expression array of 84 genes revealed statistically significant downregulation or upregulation of several genes (shown in table). b We evaluated the effect of MSC-secreted factors also in vivo. Tumor bearing mice were treated with cisplatin (3Â mg/kg) alone or in combination with 250.000 of MSC. MSC were administered i.v. in the same day as chemotherapy. We found that administration of MSC reduced the therapeutic effect of cisplatinBack to article page